SS

Saji Subrahmanyan

Active Director Director DIN 08414480
DIN 08414480 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Saji Subrahmanyan

Data last updated:

Saji Subrahmanyan is a Director at Lenimen Biotech Private Limited (since 2019). The company operates in Pharma. Lenimen Biotech Private Limited reported revenue of ₹2.04 Cr (FY 2023).

DIN 08414480
Primary Designation Director
Industry Pharma
First Appointment 08 Apr 2019
Oldest Company Age 12 yrs
Largest company Lenimen Biotech Private Limited · ₹2.04 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lenimen Biotech Private Limited U24232KL2014PTC036433
Director08 Apr 20192014₹2.04 Cr (FY 2023)Active

Directorship timeline

Open interactive timeline →
Lenimen Biotech Private Limited
Premium access

Shareholding and investment profile for Saji Subrahmanyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saji Subrahmanyan

Saji Subrahmanyan currently holds 1 directorship: Lenimen Biotech Private Limited (Director, since 08 Apr 2019, revenue ₹2.04 Cr (FY 2023)).

Saji Subrahmanyan was first appointed on 08 Apr 2019 as Director at Lenimen Biotech Private Limited.

The current boards of Saji Subrahmanyan's companies include Abdul Rahman Parappath Shibili (Lenimen Biotech Private Limited), Midhul Sasidharan Nair (Lenimen Biotech Private Limited), Pazhangat Kochumarakat Nazar (Lenimen Biotech Private Limited), Shahid Rahman Manthedath (Lenimen Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available